0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-11-22 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14500183 2022-11-22 2024-02-29 14500183 2024-02-29 14500183 2022-11-21 14500183 core:PlantMachinery 2022-11-22 2024-02-29 14500183 core:FurnitureFittings 2022-11-22 2024-02-29 14500183 bus:Director1 2022-11-22 2024-02-29 14500183 core:WithinOneYear 2024-02-29 14500183 core:AfterOneYear 2024-02-29 14500183 core:ShareCapital 2024-02-29 14500183 core:RetainedEarningsAccumulatedLosses 2024-02-29 14500183 bus:SmallEntities 2022-11-22 2024-02-29 14500183 bus:AuditExempt-NoAccountantsReport 2022-11-22 2024-02-29 14500183 bus:SmallCompaniesRegimeForAccounts 2022-11-22 2024-02-29 14500183 bus:PrivateLimitedCompanyLtd 2022-11-22 2024-02-29 14500183 bus:AbridgedAccounts 2022-11-22 2024-02-29
COMPANY REGISTRATION NUMBER: 14500183
PRESERVE SKIN CLINIC LIMITED
FILLETED UNAUDITED ABRIDGED FINANCIAL STATEMENTS
29 February 2024
PRESERVE SKIN CLINIC LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION
29 February 2024
29 Feb 24
Note
£
£
FIXED ASSETS
Tangible assets
4
29,615
CURRENT ASSETS
Stocks
800
Cash at bank and in hand
2,250
-------
3,050
CREDITORS: amounts falling due within one year
49,890
---------
NET CURRENT LIABILITIES
46,840
---------
TOTAL ASSETS LESS CURRENT LIABILITIES
( 17,225)
CREDITORS: amounts falling due after more than one year
14,000
---------
NET LIABILITIES
( 31,225)
---------
CAPITAL AND RESERVES
Called up share capital
2
Profit and loss account
( 31,227)
---------
SHAREHOLDERS DEFICIT
( 31,225)
---------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the period ending 29 February 2024 in accordance with Section 444(2A) of the Companies Act 2006.
PRESERVE SKIN CLINIC LIMITED
ABRIDGED STATEMENT OF FINANCIAL POSITION (continued)
29 February 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 25 September 2024 , and are signed on behalf of the board by:
Ms S Cragg
Director
Company registration number: 14500183
PRESERVE SKIN CLINIC LIMITED
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
PERIOD FROM 22 NOVEMBER 2022 TO 29 FEBRUARY 2024
1. General information
The company is a private company limited by shares, registered in United Kingdom. The address of the registered office is 1 Derby Road, Eastwood, Nottinghamshire, NG16 3PA, England.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
15% reducing balance
Fixtures and fittings
-
15% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Finance leases and hire purchase contracts
Assets held under finance leases and hire purchase contracts are recognised in the abridged statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
4. Tangible assets
£
Cost
At 22 November 2022
Additions
34,842
---------
At 29 February 2024
34,842
---------
Depreciation
At 22 November 2022
Charge for the period
5,227
---------
At 29 February 2024
5,227
---------
Carrying amount
At 29 February 2024
29,615
---------
5. Director's advances, credits and guarantees
Included within creditors is an amount owed to the director of £29,576. This amount is interest free, unsecured and repayable upon demand.